Top Markets
#1 Songbird Songbird +14.68%
#2 TENDIES TENDIES +13.17%
#3 DAPPOS DAPPOS +11.70%
#4 MarsCoin MarsCoin +9.87%
#5 pipedog pipedog +8.22%
#6 Prom Prom +7.80%
#7 Pons Pons +7.47%
#8 Collector Crypt Collector Crypt +7.10%
#9 Cryptopia Cryptopia +7.05%
#10 Helium Helium +6.08%
Coin of the day
Songbird Songbird
Settings
Language
ENGLISH
Currency
USD
Theme
Chongqing Lummy Pharmaceutical Co., Ltd. Chongqing Lummy Pharmaceutical Co., Ltd.

Chongqing Lummy Pharmaceutical Co., Ltd.

300006
Rank in Stocks #10090
Chongqing Lummy Pharmaceutical Co., Ltd. is a Chinese firm dedicated to the... Chongqing Lummy Pharmaceutical Co., Ltd. is a Chinese firm dedicated to the research, development, production, and distribution of a broad spectrum of pharmaceutical products. Its extensive portfolio encompasses treatments for various therapeutic areas, including oncology, infectious diseases (antibacterial, antiviral, and antifungal), liver support, and endocrine disorders. The company also develops and markets medications for the digestive, immune, blood, cardiovascular, and nervous systems, in addition to traditional Chinese patent medicines. Further offerings include electrolyte and acid-base balancing agents, nutritional supplements, large volume parenteral solutions, American ginseng preparations, and active pharmaceutical ingredients. Established in 1999, the company's headquarters are located in Chongqing, China.
Share Price
$0.84484795
Last synced: 2026-08-28
Market Cap
$892.08M
Change (1 day)
-4.11%
Change (1 year)
27.37%
Country
CN
Trade Chongqing Lummy Pharmaceutical Co., Ltd. (300006)

Category

Healthcare
P/B ratio for Chongqing Lummy Pharmaceutical Co., Ltd. (300006)
P/B ratio as of 2026 TTM: 0
According to Chongqing Lummy Pharmaceutical Co., Ltd. latest financial reports and stock price the company's current price-to-book ratio (TTM) is 0. At the end of 2026 the company had a P/B ratio of 0.
P/B ratio history for Chongqing Lummy Pharmaceutical Co., Ltd. from 2026 to 2026
P/B ratio at the end of each year
Year P/B Ratio Change
Not enough data for the provided dates.
P/B ratio for similar companies or competitors
Company P/B Ratio P/B Ratio Difference Country
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 31.0864 -
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7.4766 -
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 -74.4354 -
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 8.4776 -
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 8.008 -
US